Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

Charlotte Gredal, Anne Mette Rosenfalck, Anders Dejgaard, Jannik Hilsted

3 Citations (Scopus)

Abstract

To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.
Original languageEnglish
JournalScandinavian Journal of Clinical & Laboratory Investigation
Volume68
Issue number8
Pages (from-to)739-44
Number of pages6
ISSN0036-5513
DOIs
Publication statusPublished - 2008

Keywords

  • Blood Glucose
  • Body Weight
  • Diabetes Mellitus, Type 2
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Hyperglycemia
  • Injections, Subcutaneous
  • Insulin
  • Insulin Aspart
  • Male
  • Middle Aged
  • Placebos

Fingerprint

Dive into the research topics of 'Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart'. Together they form a unique fingerprint.

Cite this